| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MX4A
|
241.15 | 86.6M | 0.02 | 0.00 | 0.23 | — | — | 80 | 78 | 723.45 | +150.0% | 63 | 0.13 |
|
IES
|
6.74 | 118.8B | 12.26 | 1.73 | — | — | — | 69 | 56 | 8.14 | +15.5% | 88 | 1.37 |
|
NCB
|
53.45 | 329.0B | 11.91 | 1.27 | — | — | — | 69 | 51 | 69.68 | +21.0% | 87 | 1.28 |
|
NWT
|
76.64 | 232.1B | 11.93 | 1.50 | — | — | — | 69 | 54 | 97.53 | +20.2% | 88 | 1.15 |
|
UB5
|
54.50 | 84.9B | 12.08 | 1.46 | — | — | — | 68 | 53 | 68.82 | +19.4% | 87 | 1.42 |
|
TRVC
|
117.04 | 196.3B | 12.79 | 1.08 | — | — | — | 67 | 43 | 158.93 | +22.9% | 86 | 1.90 |
|
INN1
|
31.97 | 91.4B | 13.64 | 1.82 | — | — | — | 64 | 51 | 35.14 | +6.9% | 88 | 3.68 |
|
SWG
|
93.90 | 162.4B | 18.69 | 3.76 | — | — | — | 58 | 46 | 70.06 | -17.5% | 100 | 0.74 |
|
IC2
|
138.95 | 78.0B | 22.43 | 3.06 | 14.32 | — | — | 46 | 36 | 94.98 | -23.7% | 65 | 0.69 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.